CGON logo

CG Oncology, Inc. (CGON) Shareholders Equity

Annual Shareholders Equity:

$733.38M+$548.59M(+296.87%)
December 31, 2024

Summary

  • As of today, CGON annual stockholders equity is $733.38 million, with the most recent change of +$548.59 million (+296.87%) on December 31, 2024.
  • During the last 3 years, CGON annual shareholders equity has risen by +$693.13 million (+1721.96%).
  • CGON annual shareholders equity is now at all-time high.

Performance

CGON Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONbalance sheet metrics

Quarterly Shareholders Equity:

$687.64M+$17.29M(+2.58%)
September 30, 2025

Summary

  • As of today, CGON quarterly stockholders equity is $687.64 million, with the most recent change of +$17.29 million (+2.58%) on September 30, 2025.
  • Over the past year, CGON quarterly shareholders equity has increased by +$150.87 million (+28.11%).
  • CGON quarterly shareholders equity is now -6.24% below its all-time high of $733.38 million, reached on December 31, 2024.

Performance

CGON Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCGONbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

CGON Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+296.9%+28.1%
3Y3 Years+1722.0%+449.3%
5Y5 Years+1722.0%+449.3%

CGON Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+1722.0%-6.2%+449.3%
5Y5-Yearat high+1722.0%-6.2%+449.3%
All-TimeAll-Timeat high+1722.0%-6.2%+449.3%

CGON Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$687.64M(+2.6%)
Jun 2025
-
$670.36M(-4.9%)
Mar 2025
-
$704.76M(-3.9%)
Dec 2024
$733.38M
$733.38M(+36.6%)
Sep 2024
-
$536.77M(-2.8%)
DateAnnualQuarterly
Jun 2024
-
$552.36M(-2.9%)
Mar 2024
-
$568.94M(+207.9%)
Dec 2023
$184.79M(+47.6%)
$184.79M(+47.6%)
Dec 2022
$125.18M(+211.0%)
-
Dec 2022
-
$125.18M
Dec 2021
$40.25M
-

FAQ

  • What is CG Oncology, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for CG Oncology, Inc.?
  • What is CG Oncology, Inc. annual shareholders equity year-on-year change?
  • What is CG Oncology, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for CG Oncology, Inc.?
  • What is CG Oncology, Inc. quarterly shareholders equity year-on-year change?

What is CG Oncology, Inc. annual stockholders equity?

The current annual shareholders equity of CGON is $733.38M

What is the all-time high annual shareholders equity for CG Oncology, Inc.?

CG Oncology, Inc. all-time high annual stockholders equity is $733.38M

What is CG Oncology, Inc. annual shareholders equity year-on-year change?

Over the past year, CGON annual stockholders equity has changed by +$548.59M (+296.87%)

What is CG Oncology, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of CGON is $687.64M

What is the all-time high quarterly shareholders equity for CG Oncology, Inc.?

CG Oncology, Inc. all-time high quarterly stockholders equity is $733.38M

What is CG Oncology, Inc. quarterly shareholders equity year-on-year change?

Over the past year, CGON quarterly stockholders equity has changed by +$150.87M (+28.11%)
On this page